Division of Infectious Diseases and Geographic Medicine,
Centre for AIDS Research,
Division of Infectious Diseases and Geographic Medicine, Centre for AIDS Research
David Katzenstein has not added Biography.
If you are David Katzenstein and would like to personalize this page please email our Author Liaison for assistance.
Association of high HIV-1 RNA levels and homozygosity at HLA class II DRB1 in adults coinfected with Mycobacterium tuberculosis in Harare, Zimbabwe.
Human immunology Nov, 2002 | Pubmed ID: 12392855
Regulatory concerns regarding AIDS vaccine development.
AIDS & public policy journal , 1988 | Pubmed ID: 11650100
Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels.
AIDS (London, England) Feb, 2002 | Pubmed ID: 11834952
Clinical signs and symptoms in the assessment of immunodeficiency in men with subtype C HIV infection in Harare, Zimbabwe.
HIV clinical trials Mar-Apr, 2002 | Pubmed ID: 11976993
Maternal HIV-1 antibody and vertical transmission in subtype C virus infection.
Journal of acquired immune deficiency syndromes (1999) Apr, 2002 | Pubmed ID: 11981358
A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection.
AIDS (London, England) May, 2002 | Pubmed ID: 12004273
Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association Jul, 2002 | Pubmed ID: 12095387
Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359.
The Journal of infectious diseases Sep, 2002 | Pubmed ID: 12195349
Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patients.
Journal of acquired immune deficiency syndromes (1999) Oct, 2002 | Pubmed ID: 12394789
Antiretroviral treatment in resource-poor settings: clinical research priorities.
Lancet Nov, 2002 | Pubmed ID: 12433534
Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy.
The Journal of infectious diseases Jan, 2003 | Pubmed ID: 12508159
HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy.
AIDS research and human retroviruses Dec, 2002 | Pubmed ID: 12512512
Editorial comment: resistance testing--an integral part of HIV management.
The AIDS reader Jan, 2003 | Pubmed ID: 12569893
Phenotypic susceptibility and virological outcome in nucleoside-experienced patients receiving three or four antiretroviral drugs.
AIDS (London, England) Apr, 2003 | Pubmed ID: 12660529
Editorial comment: interpretation of resistance tests remains complex.
The AIDS reader Mar, 2003 | Pubmed ID: 12728869
High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment.
Journal of virology Jul, 2003 | Pubmed ID: 12805470
Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution.
AIDS reviews Jan-Mar, 2003 | Pubmed ID: 12875105
Clinical impact of the M184V mutation on switching to didanosine or maintaining lamivudine treatment in nucleoside reverse-transcriptase inhibitor-experienced patients.
The Journal of infectious diseases Aug, 2003 | Pubmed ID: 12898440
Assessing resistance costs of antiretroviral therapies via measures of future drug options.
The Journal of infectious diseases Oct, 2003 | Pubmed ID: 14513420
The evaluation of the HIV/AIDS drug access initiatives in Côte d'Ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa.
AIDS (London, England) Jul, 2003 | Pubmed ID: 14565603
Evaluation of cutpoints for phenotypic hypersusceptibility to efavirenz.
AIDS (London, England) Nov, 2003 | Pubmed ID: 14571193
Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months.
Journal of acquired immune deficiency syndromes (1999) Dec, 2003 | Pubmed ID: 14657758
Drug resistance in non-subtype B HIV-1.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology Mar, 2004 | Pubmed ID: 14962783
Genotype, phenotype, and virtual phenotype: who needs what and why?
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) Oct-Dec, 2003 | Pubmed ID: 14986515
Mycobacterium tuberculosis/HIV-1 coinfection and disease: role of human leukocyte antigen variation.
The Journal of infectious diseases Mar, 2004 | Pubmed ID: 14999612
Infant feeding practices of HIV-infected and uninfected women in Zimbabwe.
AIDS patient care and STDs Jan, 2004 | Pubmed ID: 15006194
HIV/AIDS care and treatment in sub-Saharan Africa.
AIDS reviews Oct-Dec, 2003 | Pubmed ID: 15011998
Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load.
Journal of virology Apr, 2004 | Pubmed ID: 15016844
Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359.
The Journal of infectious diseases Apr, 2004 | Pubmed ID: 15031785
The longer the better? Four years of durable, initially boosted protease treatment.
AIDS (London, England) Mar, 2004 | Pubmed ID: 15075518
Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy.
AIDS (London, England) Jul, 2004 | Pubmed ID: 15238768
Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.
JAMA : the journal of the American Medical Association Jul, 2004 | Pubmed ID: 15249575
Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects.
The Journal of infectious diseases Sep, 2004 | Pubmed ID: 15295692
Genetic correlates of efavirenz hypersusceptibility.
AIDS (London, England) Sep, 2004 | Pubmed ID: 15316338
Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa.
Journal of immunology (Baltimore, Md. : 1950) Oct, 2004 | Pubmed ID: 15383595
T lymphocytes among HIV-infected and -uninfected infants: CD4/CD8 ratio as a potential tool in diagnosis of infection in infants under the age of 2 years.
Journal of translational medicine Feb, 2005 | Pubmed ID: 15683549
Antiretroviral rounds. Resistance: how do you know if you don't know?
AIDS clinical care Mar, 2005 | Pubmed ID: 15828117
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration.
PLoS medicine Apr, 2005 | Pubmed ID: 15839752
Nonnucleoside reverse transcriptase inhibitor phenotypic hypersusceptibility can be demonstrated in different assays.
Journal of acquired immune deficiency syndromes (1999) May, 2005 | Pubmed ID: 15851917
Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa.
AIDS research and human retroviruses Apr, 2005 | Pubmed ID: 15943570
HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India.
AIDS research and human retroviruses Apr, 2005 | Pubmed ID: 15943572
Among the devils in the details are protease sequence, susceptibility, and structure in CRF02_AG viruses.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Jul, 2005 | Pubmed ID: 15983924
Signal-boosted qualitative ultrasensitive p24 antigen assay for diagnosis of subtype C HIV-1 infection in infants under the age of 2 years.
Journal of acquired immune deficiency syndromes (1999) Aug, 2005 | Pubmed ID: 16010158
Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine.
The Journal of infectious diseases Oct, 2005 | Pubmed ID: 16136470
The feasibility of voluntary counselling and HIV testing for pregnant women using community volunteers in Zimbabwe.
International journal of STD & AIDS Nov, 2005 | Pubmed ID: 16303072
The HIV-1 Non-subtype B Workgroup: an international collaboration for the collection and analysis of HIV-1 non-subtype B data.
MedGenMed : Medscape general medicine , 2005 | Pubmed ID: 16369376
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent.
Antimicrobial agents and chemotherapy Feb, 2006 | Pubmed ID: 16436728
HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes.
AIDS (London, England) Mar, 2006 | Pubmed ID: 16514293
Of molecules, macaques and global AIDS.
AIDS (London, England) Apr, 2006 | Pubmed ID: 16603861
A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102.
Journal of acquired immune deficiency syndromes (1999) Jun, 2006 | Pubmed ID: 16760795
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.
JAMA : the journal of the American Medical Association Aug, 2006 | Pubmed ID: 16905788
Affordable flow cytometry for enumeration of absolute CD4+ T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in a resource-limited setting.
Journal of translational medicine , 2006 | Pubmed ID: 16907973
Diversity, drug resistance, and the epidemic of subtype C HIV-1 in Africa.
The Journal of infectious diseases Sep, 2006 | Pubmed ID: 16921472
Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.
Topics in HIV medicine : a publication of the International AIDS Society, USA Aug-Sep, 2006 | Pubmed ID: 17016878
Factors in the delayed HIV presentation of immigrants in Northern California: implications for voluntary counseling and testing programs.
Journal of immigrant and minority health / Center for Minority Public Health Jan, 2007 | Pubmed ID: 17031578
Perceived risks and benefits of HIV testing, and predictors of acceptance of HIV counselling and testing among pregnant women in Zimbabwe.
International journal of STD & AIDS Dec, 2006 | Pubmed ID: 17212862
Non-nucleoside phenotypic hypersusceptibility cut-point determination from ACTG 359.
HIV clinical trials Mar-Apr, 2007 | Pubmed ID: 17507321
More on the treatment-tropism relationship: the impact of prior antiretroviral treatment on HIV coreceptor tropism among subjects entering AIDS clinical trials group 175.
The Journal of infectious diseases Jul, 2007 | Pubmed ID: 17570122
Laboratory indicators of mastitis are not associated with elevated HIV-1 DNA loads or predictive of HIV-1 RNA loads in breast milk.
The Journal of infectious diseases Aug, 2007 | Pubmed ID: 17624843
Drug resistance in plasma and breast milk after single-dose nevirapine in subtype C HIV type 1: population and clonal sequence analysis.
AIDS research and human retroviruses Aug, 2007 | Pubmed ID: 17725424
Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk.
PloS one , 2008 | Pubmed ID: 18431498
Genotypic susceptibility scores and HIV type 1 RNA responses in treatment-experienced subjects with HIV type 1 infection.
AIDS research and human retroviruses May, 2008 | Pubmed ID: 18462083
Cytomegalovirus and Epstein-Barr virus in breast milk are associated with HIV-1 shedding but not with mastitis.
AIDS (London, England) Jul, 2008 | Pubmed ID: 18614868
Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis.
Archives of internal medicine Sep, 2008 | Pubmed ID: 18809819
Editorial comment: a plethora or options in multidrug-resistant HIV-1 infection.
The AIDS reader Sep, 2008 | Pubmed ID: 18828232
Bayesian network analyses of resistance pathways against efavirenz and nevirapine.
AIDS (London, England) Oct, 2008 | Pubmed ID: 18832874
Envelope coreceptor tropism, drug resistance, and viral evolution among subtype C HIV-1-infected individuals receiving nonsuppressive antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) Jan, 2009 | Pubmed ID: 19295330
CCR5- and CXCR4-tropic subtype C human immunodeficiency virus type 1 isolates have a lower level of pathogenic fitness than other dominant group M subtypes: implications for the epidemic.
Journal of virology Jun, 2009 | Pubmed ID: 19297481
Lack of evidence for frequent heterosexual transmission of human herpesvirus 8 in Zimbabwe.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Jun, 2009 | Pubmed ID: 19400749
Expanding antiretroviral options in resource-limited settings--a cost-effectiveness analysis.
Journal of acquired immune deficiency syndromes (1999) Sep, 2009 | Pubmed ID: 19448557
TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories.
Journal of virological methods Aug, 2009 | Pubmed ID: 19490972
Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method.
Journal of virological methods Aug, 2009 | Pubmed ID: 19490976
Evolution and molecular epidemiology of subtype C HIV-1 in Zimbabwe.
AIDS (London, England) Nov, 2009 | Pubmed ID: 19770693
The HIV-1 Non-subtype B Workgroup: An International Collaboration for the Collection and Analysis of HIV-1 Non-subtype B Data.
Journal of the International AIDS Society , 2005 | Pubmed ID: 19825127
Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India.
Antiviral therapy , 2009 | Pubmed ID: 19918105
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.
The New England journal of medicine Dec, 2009 | Pubmed ID: 19952143
Learning and doing: operational research and access to HIV treatment in Africa.
AIDS (London, England) Jan, 2010 | Pubmed ID: 20023435
Quality of life, psychosocial health, and antiretroviral therapy among HIV-positive women in Zimbabwe.
AIDS care Dec, 2009 | Pubmed ID: 20024731
Unusual five amino acid insert within subtype C HIV-1 envelope contributes to dual-tropism (X4R5).
AIDS (London, England) Apr, 2010 | Pubmed ID: 20299967
Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.
AIDS (London, England) Jul, 2010 | Pubmed ID: 20453629
Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation.
PloS one , 2010 | Pubmed ID: 20539818
Genetic analyses of HIV-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitis.
Journal of virology Oct, 2010 | Pubmed ID: 20660189
Viral sequence analysis from HIV-infected mothers and infants: molecular evolution, diversity, and risk factors for mother-to-child transmission.
Clinics in perinatology Dec, 2010 | Pubmed ID: 21078447
Fertility desires and condom use among HIV-positive women at an antiretroviral roll-out program in Zimbabwe.
African journal of reproductive health Jun, 2010 | Pubmed ID: 21243916
Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study.
BMC public health , 2011 | Pubmed ID: 21303548
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.
Annals of internal medicine Apr, 2011 | Pubmed ID: 21320923
Adherence to drug-refill is a useful early warning indicator of virologic and immunologic failure among HIV patients on first-line ART in South Africa.
PloS one , 2011 | Pubmed ID: 21408071
Lower CD4 cell count and higher virus load, but not antiretroviral drug resistance, are associated with AIDS-defining events and mortality: an ACTG Longitudinal Linked Randomized Trials (ALLRT) analysis.
HIV clinical trials Mar-Apr, 2011 | Pubmed ID: 21498151
Detection of HIV-1 in Saliva: Implications for Case-Identification, Clinical Monitoring and Surveillance for Drug Resistance.
The open virology journal , 2010 | Pubmed ID: 21673840
Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe.
PloS one , 2011 | Pubmed ID: 21698125
Placental malaria and mother-to-child transmission of human immunodeficiency virus-1 in rural Rwanda.
The American journal of tropical medicine and hygiene Aug, 2011 | Pubmed ID: 21813835
HIV disclosure patterns, predictors, and psychosocial correlates among HIV positive women in Zimbabwe.
AIDS care , 2012 | Pubmed ID: 21902570
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.
The Journal of infectious diseases Oct, 2011 | Pubmed ID: 21917892
Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South Africa.
Journal of AIDS & clinical research Feb, 2011 | Pubmed ID: 21927716
The point of point-of-care testing.
Lancet Oct, 2011 | Pubmed ID: 22035547
Reverse transcriptase substitution at codons 208 and 228 among treatment-experienced HIV-1 subtype-C-infected Indian patients is strongly associated with thymidine analogue mutations.
Journal of acquired immune deficiency syndromes (1999) Feb, 2012 | Pubmed ID: 22245718
Primary drug resistance in South Africa: data from 10 years of surveys.
AIDS research and human retroviruses Jun, 2012 | Pubmed ID: 22251009
The incidence and correlates of symptomatic and asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae infections in selected populations in five countries.
Sexually transmitted diseases Jun, 2011 | Pubmed ID: 22256336
Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Apr, 2012 | Pubmed ID: 22323567
Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase.
PloS one , 2012 | Pubmed ID: 22363673
Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settings.
AIDS (London, England) Jul, 2012 | Pubmed ID: 22441252
Panel of prototypical recombinant infectious molecular clones resistant to nevirapine, efavirenz, etravirine, and rilpivirine.
Antimicrobial agents and chemotherapy Aug, 2012 | Pubmed ID: 22664973
Global analysis of sequence diversity within HIV-1 subtypes across geographic regions.
Future virology May, 2012 | Pubmed ID: 22822410
Comparing Peripheral Blood Mononuclear Cell DNA and Circulating Plasma viral RNA pol Genotypes of Subtype C HIV-1.
Journal of AIDS & clinical research Feb, 2012 | Pubmed ID: 23019537
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.
The Journal of infectious diseases Dec, 2012 | Pubmed ID: 23148287
Antiviral resistance and correlates of virologic failure in the first cohort of HIV-infected children gaining access to structured antiretroviral therapy in Lima, Peru: a cross-sectional analysis.
BMC infectious diseases , 2013 | Pubmed ID: 23280237
In vitro HIV-1 evolution in response to triple reverse transcriptase inhibitors & in silico phenotypic analysis.
PloS one , 2013 | Pubmed ID: 23613794
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.
The Journal of infectious diseases Jun, 2013 | Pubmed ID: 23687292
Prototypical Recombinant Multi-Protease Inhibitor Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type-1.
Antimicrobial agents and chemotherapy Jun, 2013 | Pubmed ID: 23796938
Capacity building and predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa.
Journal of the International AIDS Society , 2013 | Pubmed ID: 23845227
HIV RNA and genotype in resource-limited settings: can we do better?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Jan, 2014 | Pubmed ID: 24076967
Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Feb, 2014 | Pubmed ID: 24253247
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202.
HIV clinical trials Nov-Dec, 2013 | Pubmed ID: 24334181
Justen Manasa1,
Siva Danaviah1,
Sureshnee Pillay1,
Prevashinee Padayachee1,
Hloniphile Mthiyane1,
Charity Mkhize1,
Richard John Lessells1,
Christopher Seebregts2,
Tobias F. Rinke de Wit3,
Johannes Viljoen1,
David Katzenstein4,
Tulio De Oliveira1
1Africa Centre for Health and Population Studies, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa,
2Unit D11, Jembi Health Systems,
3Academic Medical Center, Department of Global Health, Amsterdam Institute for Global Health and Development (AIGHD), University of Amsterdam,
4Division of Infectious Diseases and Geographic Medicine, Centre for AIDS Research, Stanford Medical School
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved